Posts In: Gubba Pharma In E News

J&J Shot Loses Antibody Protection Against Omicron In Study

December 15, 2021 Gubba Pharma In E News

Johnson & Johnson’s vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain’s ability to get...

Continue Reading

Zydus Cadila gets USFDA approval to market generic schizophrenia drug

December 15, 2021 Gubba Pharma In E News

Drug firm Zydus Cadila said it has received approval from the US health regulator to market generic drug Cariprazine capsules, which are used in the...

Continue Reading

Lupin announces launch of educational mobile website Sciflix

December 1, 2021 Gubba Pharma In E News

Global pharma major Lupin announced the launch of Sciflix, an educational mobile adaptable website for medical students who are pursuing post-graduation with chest specialisation. Curated...

Continue Reading

Hyderabad-based Biological E Limited gears up to launch ‘Corbevax’ soon

December 1, 2021 Gubba Pharma In E News

The city has continued to retain its status as the vaccine capital of the country with yet another top-pharmaceutical company Biological E Limited preparing the...

Continue Reading

Sun Pharma, Dr Reddy’s And Cipla Among 55 Firms Selected For Rs 15,000 Crore PLI Scheme For Pharmaceutical Sector

December 1, 2021 Gubba Pharma In E News

The government has selected 55 pharma companies including Sun Pharma, Dr Reddy’s Laboratories and Cipla for Rs 15,000 crore Production Linked Incentive (PLI) scheme to...

Continue Reading

Sun Pharma, Lupin Recall Products In US Market, Says USFDA

November 24, 2021 Gubba Pharma In E News

Leading drugmakers Sun Pharma and Lupin are recalling different products in the US, the world’s largest market for medicines, for different reasons. As per the...

Continue Reading

AIMIL Pharma launches ayurveda-based beauty product

November 24, 2021 Gubba Pharma In E News

The Fragrance and Flavour Development Centre in Kannauj has come up with beauty products in association with the Delhi-based AIMIL Pharma in line with the...

Continue Reading

Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell remedy firm

November 24, 2021 Gubba Pharma In E News

Laurus mentioned it has signed an settlement to put money into Immunoadoptive Cell Therapy Private Limited (ImmunoACT), that is growing an indigenous CAR T-cell remedy...

Continue Reading

Here’s how Venus Remedies is striking ahead with cutting- edge tech

November 17, 2021 Gubba Pharma In E News

Venus Remedies is going from strength to strength with the adoption of bleeding-edge technology in its research, manufacturing, and communication infrastructure, striving to become a...

Continue Reading